<DOC>
	<DOCNO>NCT01861249</DOCNO>
	<brief_summary>Primary Objective : To assess long term safety tolerability SAR339658 Secondary Objective : To assess long term efficacy SAR339658</brief_summary>
	<brief_title>Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis ( UC )</brief_title>
	<detailed_description>The study period per patient include 62 week treatment , 6 week post treatment safety follow-up , follow long term safety follow-up perform form phone interview 3 , 6 , 12 , 18 24 month last administration study medication .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Inclusion criterion : Patients Ulcerative Colitis ( UC ) previously randomize complete 8week treatment ACT12688 study acceptable safety profile . Patients administrative reason could enrol LTS12593 study right completion 8week treatment ACT12688 study must enrol within 3 month end ACT12688 study Signed write informed consent Study LTS12593 Exclusion criterion : Patient adverse event lead study drug ( active placebo ) treatment discontinuation ACT12688 study . Patient abnormalities adverse event per investigator judgment would adversely affect patient 's participation longterm extension study . Use immunosuppressant ( patient immunosuppressant must discontinue immunosuppressant start LTS12593 ) . If patient start biological treatment UC wait enrol LTS12593 , must stop biological treatment must 8 week wash period start treatment SAR339658 ( antitumor necrosis factor ( TNFs ) allow ) Patients expose antiintegrin investigational drug administer end treatment ACT12688 Positive pregnancy test Breast feeding woman Women childbearing potential protect highly effective contraceptive method birth control and/or unwilling unable test pregnancy . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>